Exact Mass: 390.1543614
Exact Mass Matches: 390.1543614
Found 500 metabolites which its exact mass value is equals to given mass value 390.1543614
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Loganin
Loganin is an iridoid monoterpenoid with formula C17H26O10 that is isolated from several plant species and exhibits neuroprotective and anti-inflammatory properties. It has a role as a plant metabolite, a neuroprotective agent, an EC 3.4.23.46 (memapsin 2) inhibitor, an EC 3.2.1.20 (alpha-glucosidase) inhibitor, an anti-inflammatory agent and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a cyclopentapyran, a beta-D-glucoside, an enoate ester, a monosaccharide derivative, an iridoid monoterpenoid, a methyl ester and a secondary alcohol. It is functionally related to a loganetin. Loganin is one of the best-known of the iridoid glycosides. It is named for the Loganiaceae, having first been isolated from the seeds of a member of that plant family, namely those of Strychnos nux-vomica. It also occurs in Alstonia boonei (Apocynaceae),[1] a medicinal tree of West Africa and in the medicinal/entheogenic shrub Desfontainia spinosa (Columelliaceae) native to Central America and South America. Loganin is a natural product found in Strychnos axillaris, Lonicera japonica, and other organisms with data available. An iridoid monoterpenoid with formula C17H26O10 that is isolated from several plant species and exhibits neuroprotective and anti-inflammatory properties. Loganin, also known as loganoside, is a member of the class of compounds known as iridoid o-glycosides. Iridoid o-glycosides are iridoid monoterpenes containing a glycosyl (usually a pyranosyl) moiety linked to the iridoid skeleton. Thus, loganin is considered to be an isoprenoid lipid molecule. Loganin is soluble (in water) and a very weakly acidic compound (based on its pKa). Loganin can be found in a number of food items such as groundcherry, annual wild rice, muscadine grape, and broad bean, which makes loganin a potential biomarker for the consumption of these food products. Loganin is one of the best-known of the iridoid glycosides.It is named for the Loganiaceae,having first been isolated from the seeds of a member of that plant family, namely those of Strychnos nux-vomica. It also occurs in Alstonia boonei (Apocynaceae), a medicinal tree of West Africa and in the medicinal/entheogenic shrub Desfontainia spinosa (Columelliaceae) native to Central America and South America . Loganin is formed from loganic acid by the enzyme loganic acid O-methyltransferase (LAMT). Loganin then becomes a substrate for the enzyme secologanin synthase (SLS) to form secologanin, a secoiridoid monoterpene found as part of ipecac and terpene indole alkaloids. Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects. Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects.
Compound II(R/S)
C21H27ClN2O3 (390.17101020000007)
Chlorpheniramine maleate
C20H23ClN2O4 (390.13462680000004)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D018926 - Anti-Allergic Agents Chlorpheniramine maleate is a histamine H1 receptor antagonist with an IC50 of 12 nM[1][2][3].
DexChlorpheniramine Maleate
C20H23ClN2O4 (390.13462680000004)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Dexchlorpheniramine maleate is an antihistamine with anticholinergic properties used in the study of allergic diseases.
Todatriol glucoside
Todatriol glucoside is a constituent of the fruit of Carum ajowan (ajowan). Constituent of the fruit of Carum ajowan (ajowan)
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol is found in herbs and spices. (2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol is a constituent of Zingiber officinale (ginger) Constituent of Zingiber officinale (ginger). (2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol is found in herbs and spices.
Mesuagin
Constituent of seeds of Mammea americana (mamey). Mesuagin is found in fruits and mammee apple. Mesuagin is found in fruits. Mesuagin is a constituent of seeds of Mammea americana (mamey)
Rosmic acid
Rosmic acid is found in herbs and spices. Rosmic acid is a constituent of Rosmarinus officinalis (rosemary)
Tryptophyl-Tryptophan
Tryptophyl-Tryptophan is a dipeptied compoosed of two tryptophan residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Loganoside
Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects. Loganin is the main iridoid glycoside compound in Cornus officinalis and has anti-inflammatory and anti-shock effects.
Arctigenic acid
Epitalon
Flibanserin
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist G - Genito urinary system and sex hormones Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research[1]-[5].
Regadenoson
C15H18N8O5 (390.14000980000003)
Ethyl 5-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Pseudolaric Acid C
CID 6440704 is a natural product found in Pseudolarix amabilis and Larix kaempferi with data available. Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1]. Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1].
Yocon
A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine (has active moiety). Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
Pseudolaric
Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1]. Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1].
[3aS-(3aalpha,4alpha,5alpha,9alpha,9aalpha,9bbeta)]-5-(Acetyloxy)-2,3,3a,4,5,9,9a,9b-octahydro-9-hydroxy-6,9-dimethyl-3-methylene-2-oxoazuleno[4,5-b]furan-4-yl ester 2-methylpropanoic acid
[3aS-(3aalpha,4alpha,5alpha,9beta,9aalpha,9bbeta)]-5-(Acetyloxy)-2,3,3a,4,5,9,9a,9b-octahydro-9-hydroxy-6,9-dimethyl-3-methylene-2-oxoazuleno[4,5-b]furan-4-yl ester 2-methylpropanoic acid
Rosmic acid
6-Butyryl-5-hydroxy-4-phenylseselin
PD-0333941
CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5220; ORIGINAL_PRECURSOR_SCAN_NO 5217 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5221; ORIGINAL_PRECURSOR_SCAN_NO 5219 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5258; ORIGINAL_PRECURSOR_SCAN_NO 5256 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5239; ORIGINAL_PRECURSOR_SCAN_NO 5234 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5321; ORIGINAL_PRECURSOR_SCAN_NO 5318 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5240; ORIGINAL_PRECURSOR_SCAN_NO 5238 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9763; ORIGINAL_PRECURSOR_SCAN_NO 9762 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9786; ORIGINAL_PRECURSOR_SCAN_NO 9781 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9813; ORIGINAL_PRECURSOR_SCAN_NO 9811 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9834; ORIGINAL_PRECURSOR_SCAN_NO 9832 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9806; ORIGINAL_PRECURSOR_SCAN_NO 9804 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9850; ORIGINAL_PRECURSOR_SCAN_NO 9846
(3beta,6alpha,8alpha)-3-(acetyloxy)-8-{[2-(hydroxymethyl)acryloyl]oxy}eudesma-1,11(13)-dieno-12,6-lactone|loloanolide A|rel-(3aR,4S,5aS,8S,9S,9aS,9bR)-8-(acetyloxy)-2,3,3a,4,5,5a,8,9,9a,9b-decahydro-5a,9-dimethyl-3-methylene-2-oxonaphto[1,2-b]furan-4-yl 2-(hydroxymethyl)prop-2-enoate
2-(glycer-2-yl)-5-(2-hydroxyethyl)phenyl-O-beta-D-glucopyranoside
(3S,6R,7R,8R)-3-Hydroxy-8-acetoxysarracenyloxygermacra-1(10),4,11(13)-trien-6,12-olide
13-acetoxy-8alpha-methacryloyloxy-4beta-hydroxy-bourbon-7(11)-en-6,12-olide
15-O-butanedioylpodocarpen-5,8(14)-dien-6-hydroxy-7,13-dione|abiesanordine A
8-Ac,3-O-(3-methylbutanoyl)-2-(2,4-hexadiynylidene)-1,6-dioxaspiro[4.5]decane-3,4,8-triol
7-methoxy-8-[1-methoxy-2,4-dihydroxy-3-methylene-4-O-isovaleryl-butyl]coumarin|micromeloside C
7-methoxy-1-methyl-9H-beta-carbolin-8-yl beta-D-glucopyranoside|Ruine
4-O-methylguaiacyl glycerol 2-O-beta-D-glucopyranoside|4-O-methylguaiacylglycerol 2-O-beta-D-glucopyranoside|4-O-methylguaiacylglycerol 8-O-beta-glucopyranoside
(4R,6R,7S,8R,10S)-3-Oxo-8-acetoxysarracenyloxyjujuyensa-1,11(13)-dien-6,12-olide
(+)- justiciresinol|(+)-5-methoxylariciresinol|(+)-methoxylariciresinol
6-(2-Methylpropanoyl),8-Ac-(1alpha,5beta,6alpha,8beta,9beta,10alpha)-6,8-Dihydroxy-4-oxo-2,11(13)-pseudoguaiadien-12,9-olide|8-O-acetyl-desacyllinearifolin B-6-O-isobutyrate
3-Angeloyl,7-(2-methylpropanoyl),8-Ac-9,10-Epoxy-P-mentha-1,3,5-triene-3,7,8-triol|9-acetoxy-7-isobutyryloxy-8,10-dihydro-8,10-epoxythymol-angelate
methyl-3-(3-hydroxy-3,3-dimethylprop-1-enyl)-4-O-(beta-acetoxybutyryl)-coumarate
8-desacyl-2,3-trans-ereglomerulide-8-O-methacrylate
(+)-(6R,7S,8S)-5-methoxyisolariciresinol|(-)-5-Methoxyisolariciresinol|5-methoxy-(+)-isolariciresinol|lyoniresinol
(1R,2R)-4-O-Methylguaiacyl glycerol 3-O-??-D-glucopyranoside|(1R,2R)-4-O-methylguaiacylglycerol 3-O-beta-D-glucopyranoside|(1R,2R)-O-methylguaiacyl glycerol 3-O-beta-D-glucopyranoside|4-O-methylguaiacylglycerol 9-O-beta-glucopyranoside
1,7-Bis(3,4-dihydroxyphenyl)-3-acetoxy-5-hydroxyheptane
4,5,7-trihydroxy-3,3,5-trimethoxy-8,4-oxyneolign-7E-ene
3-hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)propyl beta-D-glucopyranoside|juniperoside XI
3-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)propyl beta-D-glucopyranoside|juniperoside X
(2R,3R,4S,5S)-6,8-dimethoxy-7-(3,7-dimethyl-4,5-epoxy-2-hydroxyocta-6-enyloxy)coumarin|altissimacoumarin F
(+)-7-methoxyariciresinol|(7S*,8R*,8S*)-3,3,7-trimethoxy-4,9,4-trihydroxy-8.8,7.0.9-lignan
(1R,3S,5S,6S)-1,5-epoxy-3,6-dihydroxy-1,7-bis(3-methoxy-4-hydroxyphenyl)heptane|kravanhol A
2,4,6-trihydroxy-3-(4-hydroxycinnamyl)dihydrochalcone|balsacone C
(2S,3aR,4S,5aR,10aR,10bR)-2-(2,5-dihydro-2-hydroxy-5-oxofuran-3-yl)-2-methoxy-3a,4,10b-trimethyl-3,3a,4,5,5a,9,10,10b-octahydro-2H,7H-naphtho[4a,4-b:1,8-b?c?]difuran-7-one|ciliatolide C
(3R*,7R*,8S*)-3-(2-Methyl)propanoyloxy-15-acetoxy-14-oxomelampa-1(10),4,11(13)-trien-8,12-olide
arctigenic acid|L-threo-4-Hydroxy-2-(4-hydroxy-3-methoxy-benzyl)-3-(3.4-dimethoxy-benzyl)-buttersaeure|L-threo-4-hydroxy-2-(4-hydroxy-3-methoxy-benzyl)-3-(3.4-dimethoxy-benzyl)-butyric acid
(2R*,3S*,7R*,8S*)-2,3-Epoxy-14-acetoxy-15-(2-methyl)propanoyloxymelampa-1(10),4,11(13)-trien-8-12-olide
(-)-caulerpenynol|7,7-C-didehydro-6-hydroxy-6,7-dihydrocaulerpenyne|caulerpenynol
(4bS,7R,8aR,9S,10S)-7-Formyloxy-4b,5,6,7,8,8a,9,10-octahydro-3,9,10-trihydroxy-4b,8,8-trimethyl-2-(2-propenyl)phenanthren-1,4-dion
(1R*,4aS*,5R*,7R*,7aR*)-1-<(beta-D-glucopyranosyl)oxy>-1,4a,5,6,7,7a-hexahydro-7-hydroxy-7methylcyclopentapyran-6-yl acetate|(1R*,4aS*,5R*,7R*,7aR*)-1-[(beta-D-glucopyranosyl)oxy]-1,4a,5,6,7,7a-hexahydro-7-hydroxy-7methylcyclopenta[c]pyran-6-yl acetate
(1(10)E,4Z,6alpha,8beta,9alpha)-9-ethoxy-6,15-dihydroxy-8-(2-methylacryloxy)-14-oxogermacra-1(10),4,11(13)-trieno-12,6-lactone|rel-(3aR,4R,5R,6E,10Z,11aS)-5-ethoxy-6-formyl-2,3,3a,4,5,8,9,11a-octahydro-10-(hydroxymethyl)-3-methylidene-2-oxocyclodeca[b]furan-4-yl 2-methylprop-2-enoate
6-(2-Methyl-2-propenoyl),1-Ac-(1alpha,6beta,10beta)-1,6,10-Trihydroxyfuranoeremophlian-9-one
(3R,6R,7R,8R)-3-Acetoxy-8-sarracenyloxyhelianga-1(10),4,11(13)-trien-6,12-olide
3beta-angeloyloxy-8beta-methoxyeremophil-7(11)-ene-12,8alpha(14beta,6alpha)-diolide|3??-Angeloyloxy-8??-methoxyeremophil-7(11)-ene-12,8??(14??,6??)-diolide
(4S,1E)-3-[(Z)-acetoxymethylene]-10,11-epoxy-7,11-dimethyldodeca-1,10-dien-8-yne-1,4-diyl diacetate|10,11-epoxycaulerpenyne
4-Butyryl-6-(2,4-dioxo-6-propyl-3,4-dihydro-2H-pyran-3-ylmethyl)-2,2-dimethyl-cyclohexan-1,3,5-trion|4-butyryl-6-(2,4-dioxo-6-propyl-3,4-dihydro-2H-pyran-3-ylmethyl)-2,2-dimethyl-cyclohexane-1,3,5-trione
7-(3,7-dimethyl-7-hydroxy-2,3-oxy-5-octenyl)oxyisofraxidin|altissimacoumarin A
(acetoxymethyl-methylene-oxo-[?]yl)methyl 2-methylpropanoate
(3R*,7R*,8S*)-3-Acetoxy-15-(2-methyl)propanoyloxy-14-oxomelampa-1(10),4,11(13)-trien-8,12-olide
15-acetoxy-1alpha-<4-hydroxymethacryloyloxy>-arbusculin B
Rauwolscine HCl
C21H27ClN2O3 (390.17101020000007)
Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM. Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM.
Yocon
C21H27ClN2O3 (390.17101020000007)
A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine (has active moiety). Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
5-hydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-h]chromen-2-one
C21H26O7_(2E,4E)-6-{[(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl]oxy}-6-oxo-2,4-hexadienoic acid
C17H26O10_2H-Pyran-5-carboxylic acid, 3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-4-(2-hydroxyethyl)-, methyl ester, (2S,3R,4S)
methyl (1S)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate
5-hydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-h]chromen-2-one [IIN-based: Match]
methyl (1S)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate_major
Ala Ala Asp Asp
Ala Cys Pro Thr
C15H26N4O6S (390.15729760000005)
Ala Cys Thr Pro
C15H26N4O6S (390.15729760000005)
Ala Asp Ala Asp
Ala Asp Asp Ala
Ala Asp Glu Gly
Ala Asp Gly Glu
Ala Glu Asp Gly
Ala Glu Gly Asp
Ala Gly Asp Glu
Ala Gly Glu Asp
Ala Pro Cys Thr
C15H26N4O6S (390.15729760000005)
Ala Pro Thr Cys
C15H26N4O6S (390.15729760000005)
Ala Ser Val Asp
Ala Thr Ala Glu
Ala Thr Cys Pro
C15H26N4O6S (390.15729760000005)
Ala Thr Glu Ala
Ala Thr Pro Cys
C15H26N4O6S (390.15729760000005)
Ala Val Asp Ser
Ala Val Ser Asp
Cys Ala Pro Thr
C15H26N4O6S (390.15729760000005)
Cys Ala Thr Pro
C15H26N4O6S (390.15729760000005)
Cys Pro Ala Thr
C15H26N4O6S (390.15729760000005)
Cys Pro Thr Ala
C15H26N4O6S (390.15729760000005)
Cys Thr Ala Pro
C15H26N4O6S (390.15729760000005)
Cys Thr Pro Ala
C15H26N4O6S (390.15729760000005)
Asp Ala Ala Asp
Asp Ala Asp Ala
Asp Ala Glu Gly
Asp Ala Gly Glu
Asp Ala Ser Val
Asp Ala Val Ser
Asp Asp Ala Ala
Asp Glu Ala Gly
Asp Glu Gly Ala
Asp Gly Ala Glu
Asp Gly Glu Ala
Asp Gly Ile Ser
Asp Gly Leu Ser
Asp Gly Ser Ile
Asp Gly Ser Leu
Asp Gly Thr Val
Asp Gly Val Thr
Asp Ile Gly Ser
Asp Ile Ser Gly
Asp Leu Gly Ser
Asp Leu Ser Gly
Asp Ser Ala Val
Asp Ser Gly Ile
Asp Ser Gly Leu
Asp Ser Ile Gly
Asp Ser Leu Gly
Asp Ser Val Ala
Asp Thr Gly Val
Asp Thr Val Gly
Asp Val Ala Ser
Asp Val Gly Thr
Asp Val Ser Ala
Asp Val Thr Gly
Glu Ala Ala Thr
Glu Ala Asp Gly
Glu Ala Gly Asp
Glu Asp Ala Gly
Glu Asp Gly Ala
Glu Glu Gly Gly
Glu Gly Ala Asp
Glu Gly Asp Ala
Glu Gly Glu Gly
Glu Gly Gly Glu
Glu Gly Ser Val
Glu Gly Val Ser
Glu Ser Gly Val
Glu Ser Val Gly
Glu Thr Ala Ala
Glu Val Gly Ser
Glu Val Ser Gly
Gly Ala Asp Glu
Gly Ala Glu Asp
Gly Asp Ala Glu
Gly Asp Glu Ala
Gly Asp Ile Ser
Gly Asp Ser Ile
Gly Asp Ser Leu
Gly Asp Thr Val
Gly Asp Val Thr
Gly Glu Ala Asp
Gly Glu Asp Ala
Gly Glu Glu Gly
Gly Glu Gly Glu
Gly Glu Ser Val
Gly Glu Val Ser
Gly Gly Glu Glu
Gly Met Pro Ser
C15H26N4O6S (390.15729760000005)
Gly Met Ser Pro
C15H26N4O6S (390.15729760000005)
Gly Asn Asn Ser
Gly Asn Ser Asn
Gly Pro Met Ser
C15H26N4O6S (390.15729760000005)
Gly Pro Ser Met
C15H26N4O6S (390.15729760000005)
Gly Ser Met Pro
C15H26N4O6S (390.15729760000005)
Gly Ser Asn Asn
Gly Ser Pro Met
C15H26N4O6S (390.15729760000005)
Met Gly Pro Ser
C15H26N4O6S (390.15729760000005)
Met Gly Ser Pro
C15H26N4O6S (390.15729760000005)
Met Pro Gly Ser
C15H26N4O6S (390.15729760000005)
Met Pro Ser Gly
C15H26N4O6S (390.15729760000005)
Met Ser Gly Pro
C15H26N4O6S (390.15729760000005)
Met Ser Pro Gly
C15H26N4O6S (390.15729760000005)
Asn Gly Asn Ser
Asn Gly Ser Asn
Asn Asn Gly Ser
Asn Asn Ser Gly
Asn Ser Gly Asn
Asn Ser Asn Gly
Pro Ala Cys Thr
C15H26N4O6S (390.15729760000005)
Pro Ala Thr Cys
C15H26N4O6S (390.15729760000005)
Pro Cys Ala Thr
C15H26N4O6S (390.15729760000005)
Pro Cys Thr Ala
C15H26N4O6S (390.15729760000005)
Pro Gly Met Ser
C15H26N4O6S (390.15729760000005)
Pro Gly Ser Met
C15H26N4O6S (390.15729760000005)
Pro Met Gly Ser
C15H26N4O6S (390.15729760000005)
Pro Met Ser Gly
C15H26N4O6S (390.15729760000005)
Pro Ser Gly Met
C15H26N4O6S (390.15729760000005)
Pro Ser Met Gly
C15H26N4O6S (390.15729760000005)
Pro Thr Ala Cys
C15H26N4O6S (390.15729760000005)
Pro Thr Cys Ala
C15H26N4O6S (390.15729760000005)
Ser Ala Asp Val
Ser Gly Met Pro
C15H26N4O6S (390.15729760000005)
Ser Gly Asn Asn
Ser Gly Pro Met
C15H26N4O6S (390.15729760000005)
Ser Met Gly Pro
C15H26N4O6S (390.15729760000005)
Ser Met Pro Gly
C15H26N4O6S (390.15729760000005)
Ser Asn Gly Asn
Ser Asn Asn Gly
Ser Pro Gly Met
C15H26N4O6S (390.15729760000005)
Ser Pro Met Gly
C15H26N4O6S (390.15729760000005)
Thr Ala Cys Pro
C15H26N4O6S (390.15729760000005)
Thr Ala Pro Cys
C15H26N4O6S (390.15729760000005)
Thr Cys Ala Pro
C15H26N4O6S (390.15729760000005)
Thr Cys Pro Ala
C15H26N4O6S (390.15729760000005)
Thr Pro Ala Cys
C15H26N4O6S (390.15729760000005)
Thr Pro Cys Ala
C15H26N4O6S (390.15729760000005)
Chidamide
TRP-TRP
A dipeptide formed from two L-tryptophan residues.
5-{4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxan-2-yl}-3-methoxybenzene-1,2-diol
Todatriol glucoside
Methyl (1S)-1-(?-D-glucopyranosyloxy)-7-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
Methyl (1S)-1-(?-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
ethyl 3-oxo-4-(triphenylphosphoranylidene)butyrate
[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium
methyl (1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate,hydrochloride
C21H27ClN2O3 (390.17101020000007)
ZK93423
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
RS 102895 hydrochloride
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Sultopride hydrochloride
C17H27ClN2O4S (390.13799720000003)
Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective antagonist of dopamine D2 receptor.
Regadenoson
C15H18N8O5 (390.14000980000003)
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS[1][2]. Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS[1][2].
N-benzyl-4-(4-methylpiperazin-1-yl)sulfonyl-2-nitroaniline
C18H22N4O4S (390.13616920000004)
2,3-bis(n-hexylthio)-1,4-naphthalenedione
C22H30O2S2 (390.16871199999997)
ALPHA,ALPHA-DI-TERT-BUTYL-ALPHA,ALPHA-DICYANO-2,3,5,6-TETRAFLUORO-1,4-BENZENEDIACETONITRILE
C20H18F4N4 (390.14675159999996)
Valganciclovir Hydrochloride
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent Valganciclovir hydrochloride is an orally active antiviral agent. Valganciclovir hydrochloride can inhibit the growth of adenoviruses and have a protective effect on immunosuppressed hamsters. Valganciclovir hydrochloride can be used for the research of Cytomegalovirus[1][2][3].
1-{[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl}piperazine dihydrochloride
Epithalon
Epitalon is an anti-aging agent and a telomerase activator. Epitalon has an inhibitory effect of the on the development of spontaneous tumors in mice, has geroprotective actions and intranasal administration increases neuronal activity. Epitalon can be used for cancer, old age and Retinitis Pigmentosa[1].
(2R)-2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl valinate hydrochloride (1:1)
Tucidinostat
C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one
C19H15FN8O (390.13527919999996)
Glycine, N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-, methyl ester, hydrochloride (1:1)
C20H23ClN2O4 (390.13462680000004)
2,8-Diazaspiro[5.5]undecane-1,3,7,9-tetrone, 2,8-bis(phenylmethyl)
3,5-Difluorophenylacetyl-Ala-Phg-OMe
C20H20F2N2O4 (390.13910640000006)
(4,6-DIFLUORO-PYRIDIN-2-YL)-HYDRAZINE
C20H26N2O4S (390.16131960000007)
N-[(2-chlorophenyl)methyl]-1-[4-[[(2-chlorophenyl)methylamino]methyl]cyclohexyl]methanamine
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites D004791 - Enzyme Inhibitors
epi-isochromophilone II
C22H27ClO4 (390.15977720000006)
An azaphilone that is 7,8-dihydro-6H-isochromen-6-one substituted by a chloro group at position 5, a 3,5-dimethylhepta-1,3-dien-1-yl group at position 3, a hydroxy group at position 7, a methyl group at position 7 and a 2-oxopropyl group at position 8. Isolated from Chaetomium cupreum, it exhibits antifungal activity.
1-(3,4-Dimethoxyphenyl)sulfonyl-4-(2,6-dimethylphenyl)piperazine
C20H26N2O4S (390.16131960000007)
4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2,6-dimethoxyphenol
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide
C18H22N4O4S (390.13616920000004)
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide
C18H22N4O4S (390.13616920000004)
1-Propene-1,2,3-tricarboxylic acid, tris(trimethylsilyl) ester, (E)-
5-(7-(6-Chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole
C21H27ClN2O3 (390.17101020000007)
Flibanserin
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist G - Genito urinary system and sex hormones Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research[1]-[5].
Yohimbine hydrochloride
C21H27ClN2O3 (390.17101020000007)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
(-)-5-Methoxyisolariciresinol
A lignan that is 5,6,7,8-tetrahydronaphthalen-2-ol substituted by two hydroxymethyl groups at positions 6 and 7, a methoxy group at position 3 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 8. It has been isolated from the stems of Sinocalamus affinis.
5-chloro-2-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)-N-(6-(3-methoxybenzamido)pyridin-3-yl)isonicotinamide
3-[(3,4-dimethoxyphenyl)methyl]-4-hydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanoic acid
8-Demethyl-8-(methylamino)riboflavin
C17H20N5O6- (390.14135200000004)
(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-3-hexylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoate
C16H28N3O6S- (390.16987280000006)
N-acetyldemethylphosphinothricyl-L-alanyl-L-leucine
Sodium prasterone sulfate
Dehydroepiandrosterone sulfate sodium salt (DHEAS) is the most abundant circulating steroid in human. Dehydroepiandrosterone sulfate sodium salt (DHEAS) affects steroid hormone biosynthesis on a molecular level resulting in an increased formation of pregnenolone[1].
Glu-Gly-Trp
A tripeptide composed of L-glutamic acid, glycine and L-tryptophan joined in sequence by peptide linkages.
Trp-Ala-Asp
A tripeptide composed of L-tryptophan, L-alanine, and L-aspartic acid joined by a peptide linkage.
Ala-Ala-Asp-Asp
A tetrapeptide composed of two L-alanine units linked to two L-aspartic acid units by peptide linkages.
2-[[4-Cyano-6,6,7-trimethyl-1-(4-morpholinyl)-5,8-dihydro-2,7-naphthyridin-3-yl]thio]acetic acid methyl ester
N-[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-N-cyclohexyl-2-furancarboxamide
C20H23ClN2O4 (390.13462680000004)
Cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester
C20H26N2O4S (390.16131960000007)
3-(1-Methyl-2-benzimidazolyl)-1-phenyl-2-pyrrolo[3,2-b]quinoxalinamine
1-(2,3-dihydroindol-1-yl)-2-[(5,5-dimethyl-6H-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)thio]ethanone
1-[2-(3,4-dimethoxyphenyl)ethyl]-6-propyl-2-sulfanylidene-7,8-dihydro-5H-pyrimido[4,5-d]pyrimidin-4-one
N-(2-furanylmethyl)-3-[3-[(4-methoxyphenyl)methyl]-2-imidazo[4,5-b]pyridinyl]propanamide
(4-Methylphenyl)-[4-[4-nitro-2-(1-pyrrolyl)phenyl]-1-piperazinyl]methanone
5-Methoxy-8-(2-hydroxy-3-buthoxy-3-methylbutyloxy)psoralen
A member of the class of psoralens that is psoralen substituted by a methoxy group at position 4 and a [(2R)-3-butoxy-2-hydroxy-3-methylbutyl]oxy group at position 9. Isolated from the roots of Angelica dahurica, it exhibits inhibitory activity against COX-2 and 5-lipooxygenase.
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2S,3R,4S)-3-[4-(cyclohexen-1-yl)phenyl]-1-(3-fluorobenzoyl)-4-(hydroxymethyl)azetidine-2-carbonitrile
C24H23FN2O2 (390.17434699999995)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
(2S,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(4R)-4-[(2R,3R,5R,6S)-3-hydroxy-5-(1H-indole-3-carbonyloxy)-6-methyloxan-2-yl]oxypentanoate
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetic acid methyl ester
(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C24H23FN2O2 (390.17434699999995)
(4-fluorophenyl)-[(1S,5R)-7-[4-(2-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
4-acetyl-1-[2-(1H-indol-3-yl)ethyl]-5-(3-methoxyphenyl)pyrrolidine-2,3-dione
(6Z)-6-[[4-(diethylamino)phenyl]methylidene]-3-(2-methylphenyl)-[1,3]thiazolo[2,3-c][1,2,4]triazol-5-one
3-[(2E)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-4-methyl-2-(2-phenylhydrazinylidene)-2H-pyrrol-3-yl]propanoic acid
methyl (3aR,4R,5R,6E,10E,11aR)-5-hydroxy-10-methyl-4-[(Z)-2-methylbut-2-enoyl]oxy-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
5-[7-[2-Chloro-4-(4-methyl-4,5-dihydrooxazol-2-yl)phenoxy]heptyl]-3-methyl-isoxazole
C21H27ClN2O3 (390.17101020000007)
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol
(+)-5-methoxylariciresinol
A lignan that is (+)-lariciresinol substituted by a methoxy group at position 5. It has been isolated from the stems of Sinocalamus affinis.
sodium dehydroepiandrosterone sulfate
An organic sodium salt that is the monosodium salt of dehydroepiandrosterone sulfate.
Emraclidine
Emraclidine (CVL-231) is a muscarinic M4 receptor positive allosteric modulator (WO2018002760, compound 11). Emraclidine can be used for the research of neurological diseases[1].
MARK4 inhibitor 1
MARK4 inhibitor 1 is a potent and selective microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM. MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis[1].
RSK4-IN-1
RSK4-IN-1 is a potent RSK4 inhibitor with a IC50 value of 9.5 nM. RSK4-IN-1 has antitumor activity[1].
(1r,2r,5r,6r,7s,8s)-2,8-dihydroxy-1-methoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-6-methyl-5-(prop-2-en-1-yl)bicyclo[3.2.1]octan-3-one
(2r,3r,4s,5s,6r)-2-{[(1r,2s)-1-(3,4-dimethoxyphenyl)-1,3-dihydroxypropan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3as,4r,5s,9s,9as,9bs)-5-(acetyloxy)-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(1s,4ar,7s,7as)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
methyl (1s,4as,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
(1s,2r,5s,6r,9r,10r)-8-formyl-6,10-dihydroxy-4,4-dimethyl-12-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0²,⁶]tridec-7-en-5-yl (2z)-hex-2-enoate
8-(acetyloxy)-2-(hexa-2,4-diyn-1-ylidene)-4-hydroxy-1,6-dioxaspiro[4.5]decan-3-yl 3-methylbutanoate
methyl (1r,4as,7s,7as)-7-hydroxy-7-methyl-1-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
14-methoxy-3-methyl-9-methylidene-8-oxo-4,7,15-trioxatetracyclo[11.2.1.0³,⁵.0⁶,¹⁰]hexadec-13(16)-en-11-yl 2-methylbut-2-enoate
(1s,2r,4r,6s,8r,9z,11s)-8-(acetyloxy)-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 2-methylprop-2-enoate
2-(hydroxymethyl)-1-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-2,12-dien-9-yl 2-methylbut-2-enoate
4-{hydroxy[(3s,4s)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl}-2,6-dimethoxyphenol
methyl 11-hydroxy-4-[(2-methylbut-2-enoyl)oxy]-3,10-dimethylidene-2-oxo-3ah,4h,5h,8h,9h,11h,11ah-cyclodeca[b]furan-6-carboxylate
methyl (1s,4as,6s,7r,7as)-6-hydroxy-7-methyl-1-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1r,4ar,7r,7ar)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
(3ar,4r,9r,11ar)-9-(acetyloxy)-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl (2z)-2-hydroxybut-2-enoate
2-({6-hydroxy-4-[hydroxy(methoxy)methyl]-7-methylidene-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
[(1r,3s,7r,9r)-1-[(acetyloxy)methyl]-6-methylidene-5-oxo-4,12-dioxatricyclo[7.5.0.0³,⁷]tetradeca-10,13-dien-10-yl]methyl 2-methylpropanoate
(2e,4e)-5-[(1r,7s,8r,9r)-7-hydroxy-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
8-hydroxy-4'-methyl-6,9-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-3,2'-oxetan]-4-yl 2-(hydroxymethyl)prop-2-enoate
(3ar,4r,11ar)-10-[(acetyloxy)methyl]-6-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(2s,3r,4s,5s,6r)-2-[3-hydroxy-2-methyl-5-(2-phenylethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2z,5z,9e)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethylidene]-11-hydroxy-6-(hydroxymethyl)-10-methylundeca-5,9-dienoic acid
methyl (2s,4ar,6ar,10ar,10br)-2-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-6a,10b-dimethyl-4-oxo-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
(3s,4s)-3-hydroxy-4-methoxy-4-(7-methoxy-2-oxochromen-8-yl)-2-methylidenebutyl 3-methylbutanoate
(1s,4as,7s,7as)-4a-hydroxy-7-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
methyl (1s,4ar,5s,7s,7ar)-5-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
(1r)-1-(5,7-dimethoxy-2-oxochromen-8-yl)-3-methyl-2-oxobutyl 3-methylbutanoate
10-[(acetyloxy)methyl]-6-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(4ar,5s,6r,6as,11as,11br)-4a,6-dihydroxy-4,4,11b-trimethyl-1,7-dioxo-2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
[5,8-dihydroxy-7-(2-hydroxypropyl)-1,4a-dimethyl-6,10-dioxo-2,3,4,10a-tetrahydrophenanthren-1-yl]methyl formate
(1s,4ar,7s,7as)-4a-hydroxy-7-methyl-1-{[(2r,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
(1e,3z,4s,6e)-1-(acetyloxy)-3-[(acetyloxy)methylidene]-9-[(2r)-3,3-dimethyloxiran-2-yl]-7-methylnona-1,6-dien-8-yn-4-yl acetate
6-({9b-hydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl}oxy)-6-oxohexa-2,4-dienoic acid
(7r,8r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-hydroxy-7-methyl-8-(2-oxopropyl)-8h-isochromen-6-one
C22H27ClO4 (390.15977720000006)